7．Tsujino S, Tsuda M, Ito J, Deguchi S, Taha TY, Nasser H, Wang L, Rosecrans J, Suzuki R, Suzuki S, Yoshimatsu K, Ott M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ikeda T, Takayama K, Sato K, Tanaka S, Tamura T, Fukuhara T.A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity.bioRxiv [Preprint].10.1101/2025.05.28.656516.2025.
6．Mitsunaga S, Tamura T, Nyampong S, Fukuhara T, Shimoda H, Hayasaka D.Reverse genetics system for Tick-borne encephalitis virus using Circular Polymerase Extension Reaction.Infect Genet Evol.10.1016/j.meegid.2025.105776.2025.
5．Kondo T, Suzuki R, Yajima H, Kawahara S, Yamaya K, Ichikawa T, Tsujino S, Suzuki S, Tamura T, Hashiguchi T, Fukuhara T.Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.J Virol.10.1128/jvi.00543-25.2025.
4．Iriyama C, Ichikawa T, Tamura T, Takahata M, Ishio T, Ibata M, Kawai R, Iwata M, Suzuki M, Adachi H, Nao N, Suzuki H, Kawai A, Kamiyama A, Suzuki T, Hirata Y, Iida S, Katano H, Ishii Y, Tsuji T, Oda Y, Tanaka S, Okazaki N, Katayama Y, Nakagawa S, Tsukamoto T, Doi Y, Fukuhara T, Murata T, Tomita A.Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients.PNAS Nexus.4(4).10.1093/pnasnexus/pgaf085.2025.
3．Kobayashi N, Suzuki S, Sakamoto Y, Suzuki R, Mori K, Kosugi Y, Saito T, Ma Y, Liang L, Izumi T, Noda K, Okuzaki D, Kanegae Y, Hayashi S, Tanaka Y, Yamashita A, Moriishi K, Matsuura Y, Takeuchi O, Tamura T, Taketomi A, Fukuhara T.NEDD4-binding protein 1 suppresses hepatitis B virus replication by regulating viral RNAs.J Gen Virol.106(3).10.1099/jgv.0.002082.2025.
2．Kida I, Tamura T, Kuroda Y, Fukuhara T, Maeda K, Matsuno K.Application of versatile reverse genetics system for feline coronavirus.Microbiol Spectr.13(4).10.1128/spectrum.02692-24.2025.
1．Inoue A, Ichikawa T, Wada D, Maruyama S, Shimazu H, Kashihara M, Okuda K, Saito F,Fukuhara T, Nakamori Y.M49L and other drug resistance mutations emerging in individuals after administration of ensitrelvir in Japanese clinical settings.Antiviral Res.10.1016/j.antiviral.2025.106118.2025.